|Day Low/High||33.44 / 34.45|
|52 Wk Low/High||27.88 / 43.08|
Let's look at the cold, hard facts around the vaccine rollout.
Plus, Coinbase files for an eventual initial public offering that should draw a ton of interest.
The stock hasn't done much of late, but perhaps FedEx's earnings report Thursday will offer clues of what's going on in delivery.
The Russell 2000 is now up 7% for December, twice the increase for the Nasdaq Composite.
We have bets coming from all directions, and holiday joy abounds as the wagerers move up their stocks with their buying. Let's see how this could play out.
I fear our legislators see these statistics and misunderstand the plight of the lower to middle class American in this environment.
Small caps stayed green while breadth lagged, and the S&P 500 has gone red for four days straight -- now, can we rally?
I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.
Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).
Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.
If it doesn't end soon, the frenzy for select tech names could last until vaccines drive changes in consumer spending, or until inflation begins picking up.
The sooner that we get jabbed the more likely the economy can spring back to life.
There is little to no fear in the air, relative to what we as investors, and we as a people, have been through.
Most important come Inauguration Day is the seamless transition of leadership over 'Operation Warp Speed'.
The Divine Ms M and I Agree -- traders and investors should stop trying to make fetch happen.
Plus, what really is going to be the shape of this recovery?
Sure, stocks need to rest, but here's why I'm watching this ETF for the industrials. Also, let's look at the dollar and construction.
The level of new highs is a clear indication that market players are still working hard to put money to work and are willing to chase strength to do so.
The market appears to be trading off on news that Pfizer expects to ship half of the Covid-19 vaccines it originally planned for this year, because of supply-chain problems. But the pharma company still expects to roll out more than a billion doses ...
The great news about the pent-up demand rally? While these stocks have been creeping up they are now going to explode higher.
The RMPIA also tops other indexes for year, shooting ahead 29%.
Also, Salesforce posts successful quarter and announces Slack acquisition to effectively take on Microsoft.
I think I'll just forget to put a new price target on this name for a while. All of my prior sales were mistakes.
There are a number of pros for being long either UPS or FDX.
The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.
All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
I will come back to these names over and over again as we are now in the sweet spot for many.
A lot has happened over the past couple weeks, but little has changed. Let's dig in.
None of these questions have been answered which is why I see chaos ahead as we can't even imagine this process working.